Antifungals
Recent studies from Belgium, Germany and the United States add new data to antifungals research
Published in Surgery Litigation and Law Weekly, January 19th, 2007
Study 1: Researchers detail in "Preemptive antifungal therapy: still a way to go," new data in antifungals. According to a study from Leuven, Belgium, "Early treatment of invasive mold infections improves the outcome. Therapy is often delayed, however, because available diagnostic tools such as culture, microscopy and conventional radiology lack sensitivity; consequently, empirical initiation of antifungal therapy has been advocated, particularly for patients with prolonged unexplained neutropenic fever."
"Much recent progress has been made in the development...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Legal Issues
Motley Rice files suit against manufacturer of failed hernia repair patch - Psychiatry
New psychiatry study results reported from University of Heidelberg - Abscess Therapy
Reports from Hospital, Department of Internal Medicine advance knowledge in abscess therapy - Abscess Therapy
Research from University of Munich reveals new findings on abscess therapy - Acute Cholecystitis
Studies from Aarhus University update current data on acute cholecystitis - Adenoid Cystic Cancer
Research from Tokyo Women's Medical University, Neurological Institute broadens understanding of adenoid cystic cancer - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
